Home HomeSwedenLivingWorld world_2_fill WorldBusiness BusinessSports sports-soccer SportsEntertainmentEntertain

Bioarctic

The UK Approves Alzheimer's Medication

Despite a no in July from the European Medicines Agency EMA, the drug Leqembi is now approved for treatment of Alzheimer's patients in the United Kingdom. .
The UK Approves Alzheimer's Medication

Alzheimer's medicine generates millions for Swedish Bioarctic

The sale of the Alzheimer's medicine Leqembi has generated 6. 3 billion yen, equivalent to around 450 million kronor, during the second quarter.
Alzheimer's medicine generates millions for Swedish Bioarctic

Medicine Stop a Hard Blow for Alzheimer's Patients

The disappointment is great since a new drug against Alzheimer's has been rejected by the EU's pharmaceutical authority. It is outrageous, says Liselotte Jansson at the Alzheimer's Foundation.
Medicine Stop a Hard Blow for Alzheimer's Patients

More approve Alzheimer's medication

Israel, and just the other day Hong Kong, has now approved the Alzheimer's drug Leqembi for use, which the USA, Japan, South Korea, and China have done previously. This is stated by the Swedish pharmaceutical company Bioarctic in a press release.
More approve Alzheimer's medication

Categories

Information

About Sweden Herald

  • Stay informed with the latest news and updates from Sweden in English. From daily news and events happening now, to recaps of what happened in Sweden last night, our coverage keeps you updated. Swedish news today.
  • © Sweden Herald